CVS Health Corporation Furnishes Strong Results and Raises Full-Year Guidance
Summary
CVS Health Corporation announced strong operating results for the three months ended March 31, 2026, via a press release (Ex. 99.1) furnished on May 6, 2026. The company reported a significant increase in first-quarter total revenues and strong EPS figures. Notably, CVS Health also raised its full-year 2026 guidance for GAAP diluted EPS, Adjusted EPS, and cash flow from operations, reflecting positive performance across its enterprise. * total revenues: $100.4 billion, up 6.2% year-over-year. * GAAP diluted EPS: $2.30; Adjusted EPS: $2.57. * Full-year 2026 GAAP diluted EPS guidance raised to $6.24-$6.44. * Full-year 2026 Adjusted EPS guidance raised to $7.30-$7.50. * Full-year 2026 cash flow from operations guidance raised to at least $9.5 billion.
Why It Matters
This update is material for investors as CVS Health Corporation reported strong first-quarter results, including a 6.2% year-over-year revenue increase to $100.4 billion, and significantly raised its full-year 2026 guidance for both GAAP and Adjusted EPS, as well as cash flow from operations, signaling an improved outlook and operational confidence.
These filing summaries are free and always will be. If this helped you spot material events, consider supporting us.
Want to see how CVS traded around this filing?
Check real-time charts and technical analysis on TradingView to see market reaction to this event.
View CVS Charts on TradingViewAffiliate link
Is this filing part of a pattern?
One disclosure is noise. Get a structured briefing covering 12 months of SEC filings, disclosure signals, and what to watch next.
Filing Details
Reported Items
Additional Information
- CIK Number
- 0000064803
- Filing Date
- Wednesday, May 6, 2026
- Filing Time
- 12:00 AM UTC
- Form Type
- 8-K
- Materiality Level
- high
- Sentiment
- positive